---
title: "SUPN 股票警報：Halper Sadeh LLC 正在調查 Supernus 製藥公司是否為其股東爭取到了公平的價格"
type: "News"
locale: "zh-HK"
url: "https://longbridge.com/zh-HK/news/297401736.md"
description: "Halper Sadeh LLC 正在調查 Supernus Pharmaceuticals, Inc. 在擬議出售給 Indivior Pharmaceuticals 的過程中是否為股東獲得了公平的價格。該律師事務所指控存在潛在的信託責任違反和聯邦證券法的違規行為，理由是未能確保最佳價格、未進行公平的銷售流程或未披露重要信息。鼓勵股東聯繫該事務所，討論他們在此次交易中的權利和選擇"
datetime: "2026-08-29T11:32:06.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/297401736.md)
  - [en](https://longbridge.com/en/news/297401736.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/297401736.md)
generator: "portal-rs"
---

# SUPN 股票警報：Halper Sadeh LLC 正在調查 Supernus 製藥公司是否為其股東爭取到了公平的價格

**SUPN Stock Alert: Halper Sadeh LLC is Investigating Whether Supernus Pharmaceuticals, Inc. is Obtaining a Fair Price for its Shareholders**

***Insiders may stand to receive substantial financial benefits not available to ordinary shareholders.***

***The proposed transaction may contain terms that could limit superior competing offers.***

***Shareholders are encouraged to contact the firm to discuss their rights and options at no cost or obligation.******We would handle any matter on a contingent fee basis, whereby you would not be responsible for out-of-pocket payment of our legal fees or expenses.***

Halper Sadeh LLC, an investor rights law firm, is investigating the sale of Supernus Pharmaceuticals, Inc. (NASDAQ: SUPN) to Indivior Pharmaceuticals, Inc. for 1.5401 common shares of Indivior for each share of Supernus.

Halper Sadeh encourages Supernus shareholders to **click here to learn more about their rights and options**or contact Daniel Sadeh or Zachary Halper **free of charge** at (212) 763-0060 or **sadeh@halpersadeh.com** or **zhalper@halpersadeh.com**.

The investigation concerns whether Supernus and its board of directors violated the federal securities laws and/or breached their fiduciary duties by failing to: (1) obtain the best possible price for Supernus shareholders; (2) conduct a fair sales process free of any conflicts of interests; and (3) disclose all material information for Supernus shareholders to evaluate the transaction.

On behalf of shareholders, Halper Sadeh LLC may seek increased consideration, additional disclosures, or other relief and benefits.

Halper Sadeh LLC represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Halper Sadeh LLC  
One World Trade Center  
85th Floor  
New York, NY 10007  
Daniel Sadeh, Esq.  
Zachary Halper, Esq.  
(212) 763-0060  
sadeh@halpersadeh.com  
zhalper@halpersadeh.com  
https://www.halpersadeh.com

View source version on businesswire.com: https://www.businesswire.com/news/home/20260829451217/en/

### 相關股票

- [SUPN.US](https://longbridge.com/zh-HK/quote/SUPN.US.md)
- [INDV.US](https://longbridge.com/zh-HK/quote/INDV.US.md)

## 相關資訊與研究

- [Supernus 製藥（NASDAQ:SUPN）股價創下 1 年新低 - 現在是賣出的時候嗎？](https://longbridge.com/zh-HK/news/298351096.md)
- [Supernus 製藥的管理層出席了 Cantor 全球醫療保健會議的爐邊談話](https://longbridge.com/zh-HK/news/297827223.md)
- [Alembic Pharmaceuticals 在迪拜設立全資子公司以促進全球擴張](https://longbridge.com/zh-HK/news/298223880.md)
- [DSGR 股票警報：Halper Sadeh LLC 正在調查 Distribution Solutions Group, Inc.是否為其股東爭取到了合理的價格](https://longbridge.com/zh-HK/news/298112585.md)
- [惠靈頓管理集團 LLP 在 Corvus 製藥公司持有價值 4081 萬美元的股票頭寸 $CRVS](https://longbridge.com/zh-HK/news/298104940.md)

---
> **免責聲明: 本文僅供參考，不構成任何投資建議。**